This Article Full Text Full Text (PDF) Publisher's Note Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weber, A. Articles by Christiansen, H. Search for Related Content PubMed PubMed Citation Articles by Weber, A. Articles by Christiansen, H. Social Bookmarking                            What's this?

Coamplification of DDX1 Correlates With an Improved Survival Probability in Children With MYCN-Amplified Human Neuroblastoma

From the Children's Hospital, Pediatric Hematology and Oncology, University of Marburg, Marburg, Germany

Address reprint requests to Holger Christiansen, MD, The Children's Hospital of Marburg, Pedriatric Oncology and Hematology, Neuroblastoma Research Laboratory, Deutschhausstrasse 12, 35037 Marburg, Germany; e-mail:Holger.Christiansen{at}staff.uni-marburg.de

PURPOSE: Amplification of the MYCN oncogene at chromosome 2p24-25 identifies an aggressive subtype of human neuroblastoma with a poor clinical outcome. Differences in amplicon structure and coamplification of genes telomeric and centromeric to the MYCN oncogene have previously been described. A relevant role of gene coamplification for neuroblastoma pathogenesis remains elusive.

PATIENTS AND METHODS: We analyzed 98 primary neuroblastoma tumors with MYCN amplification for coamplification of seven additional genes at chromosome 2p24-25 (DDX1, NAG, NSE1, LPIN1, EST-AA581763, SMC6, and SDC1). Two semiquantitative multiplex polymerase chain reactions were used to obtain the amplification status of the target genes in relation to a reference gene on chromosome 2q (Inhibin-beta-b). Furthermore, mRNA expression pattern of coamplified genes in a subset of tumors was analyzed.

RESULTS: Our results show that the frequency of gene coamplification on 2p24-25 in neuroblastoma is correlated directly to the physical distance to MYCN. Coamplification is correlated to an upregulated gene expression for DDX1 and NAG. Coamplification of the DDX1 gene within 400kb telomeric to MYCN identifies a subgroup of advanced stage neuroblastoma tumors with a more favorable outcome (P = .027, log-rank test). A high expression level of DDX1 is associated with a trend towards a better survival probability (P = .058, log-rank test).

CONCLUSION: Our results indicate that DDX1 coamplification correlates with a better prognosis and improved patient survival in MYCN-amplified neurobastoma.

This work contains parts of the doctoral theses of Patricia Imisch.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. Aoki, S. Ichimura, A. Itoh, M. Kuramoto, T. Shinkawa, T. Isobe, and M. Tagaya Identification of the Neuroblastoma-amplified Gene Product as a Component of the Syntaxin 18 Complex Implicated in Golgi-to-Endoplasmic Reticulum Retrograde Transport Mol. Biol. Cell, June 1, 2009; 20(11): 2639 - 2649. [Abstract] [Full Text] [PDF]

				J. Theissen, M. Boensch, R. Spitz, D. Betts, S. Stegmaier, H. Christiansen, F. Niggli, F. Schilling, M. Schwab, T. Simon, et al. Heterogeneity of the MYCN Oncogene in Neuroblastoma Clin. Cancer Res., March 15, 2009; 15(6): 2085 - 2090. [Abstract] [Full Text] [PDF]

				M. D. Hogarty, M. D. Norris, K. Davis, X. Liu, N. F. Evageliou, C. S. Hayes, B. Pawel, R. Guo, H. Zhao, E. Sekyere, et al. ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma Cancer Res., December 1, 2008; 68(23): 9735 - 9745. [Abstract] [Full Text] [PDF]

				C. Stock, E. Bozsaky, F. Watzinger, U. Poetschger, L. Orel, T. Lion, A. Kowalska, and P. F. Ambros Genes Proximal and Distal to MYCN Are Highly Expressed in Human Neuroblastoma as Visualized by Comparative Expressed Sequence Hybridization Am. J. Pathol., January 1, 2008; 172(1): 203 - 214. [Abstract] [Full Text] [PDF]

				Y. Zeng, N. Huebener, S. Fest, S. Weixler, U. Schroeder, G. Gaedicke, R. Xiang, A. Schramm, A. Eggert, R. A. Reisfeld, et al. Fractalkine (CX3CL1)- and Interleukin-2-Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells Cancer Res., March 1, 2007; 67(5): 2331 - 2338. [Abstract] [Full Text] [PDF]

				A. Weber, S. Starke, E. Bergmann, and H. Christiansen The Coamplification Pattern of the MYCN Amplicon Is an Invariable Attribute of Most MYCN-Amplified Human Neuroblastomas Clin. Cancer Res., December 15, 2006; 12(24): 7316 - 7321. [Abstract] [Full Text] [PDF]

				M. Bredel, C. Bredel, D. Juric, G. R. Harsh, H. Vogel, L. D. Recht, and B. I. Sikic High-Resolution Genome-Wide Mapping of Genetic Alterations in Human Glial Brain Tumors Cancer Res., May 15, 2005; 65(10): 4088 - 4096. [Abstract] [Full Text] [PDF]

				K. De Preter, F. Speleman, V. Combaret, J. Lunec, J. Board, A. Pearson, A. De Paepe, N. Van Roy, G. Laureys, and J. Vandesompele No Evidence for Correlation of DDX1 Gene Amplification With Improved Survival Probability in Patients With MYCN-Amplified Neuroblastomas J. Clin. Oncol., May 1, 2005; 23(13): 3167 - 3168. [Full Text] [PDF]

				A. Weber, P. Imisch, E. Bergmann, and H. Christiansen In Reply: J. Clin. Oncol., May 1, 2005; 23(13): 3168 - 3170. [Full Text] [PDF]